James Kilts - Pfizer Independent Director

<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:3em;padding-top: 38px;;'>PFE</div>
PFE -- USA Stock  

Trending

  Director
Mr. James Marshall Kilts is an Independent Director of Pfizer Inc., since September 27, 2007. He is Founding Partner, Centerview Capital, a private equity firm, since 2006. Vice Chairman, The Procter Gamble Company, from 2005 to 2006. Chairman and Chief Executive Officer, The Gillette Company, from 2001 to 2005 and President, Gillette, from 2003 to 2005. President and Chief Executive Officer, Nabisco Group Holdings Corporationrationration, from 1998 until its acquisition in 2000. NonExecutive Director of the Board of Nielsen Holdings PLC, Chairman of the Board of Nielsen Holdings and Chairman of the Nielsen Company B.V. . Executive Chairman of the Board of Conyers Park Acquisition Corporationrationration . Director of MetLife, Inc. and Unifi, Inc. . Chairman of Big Heart Pet Brands until March 2015 and Director of Meadwestvaco Corporationrationration until April 2014. Life Trustee of Knox College and Trustee of the University of Chicago, a member of the Board of Overseers of Weill Cornell Medicine, and Founder and CoChair, Steering Committee, of the Kilts Center for Marketing at the University of Chicago Booth School of Business. his tenure as CEO of Gillette and Nabisco and as Vice Chairman of Procter Gamble provides valuable business, leadership and management experience, including expertise in cost management, value creation and resource allocation. In addition, his knowledge of consumer businesses has given him insights into reaching consumers and the importance of innovationboth important aspects of Pfizers business. Through his service on various compensation committees, including ours, Mr. Kilts has a strong understanding of executive compensation and related areas. Through his service on the board of MetLife, Inc., an insurance company, Mr. Kilts offers a view of healthcare from another perspective.
Age: 71  Director Since 2007      
212 733-2323  www.pfizer.com

James Kilts Latest Insider Activity

Pfizer Management Efficiency

Pfizer Inc has Return on Asset of 8.0E-4 % which means that on every $100 spent on asset it made $8.0E-4 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 0.2094 % implying that it generated $0.2094 on every 100 dollars invested. Pfizer management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. The current year Return on Investment is expected to grow to 11.02, whereas Return on Average Assets are expected to decline to 8.28. Pfizer Tax Assets are expected to significantly decrease based on the last few years of reporting. The last year's Tax Assets were at 5.44 Billion. The current year Revenue to Assets is expected to grow to 0.35, whereas Assets Non Current are expected to decline to about 124.2 B. Pfizer Tax Liabilities is expected to significantly decrease based on the last few years of reporting. The last year's Tax Liabilities was at 18.68 Billion
The company has 47.96 B in debt with debt to equity (D/E) ratio of 80.0 . This implies that the company may be unable to create cash to meet all of its financial commitments. Pfizer Inc has Current Ratio of 1.44 which is typical for the industry and considered as normal.

Similar Executives

Showing few of many executives

DIRECTOR Since

George SingRegeneron Pharmaceuticals
1988
Ravi BhoothalingamDr Reddys Laboratories
2000
David GreenwayVertex Pharmaceuticals Incorpor
2017
Gary KunklePerrigo Company Plc
2009
Donal OConnorPerrigo Company Plc
2014
Kalpana MorpariaDr Reddys Laboratories
2007
Bradley AlfordPerrigo Company Plc
2017
Alan GarberVertex Pharmaceuticals Incorpor
2017
Sangeeta BhatiaVertex Pharmaceuticals Incorpor
2015
William DoyleZoetis Inc
2015
Allan ObermanDr Reddys Laboratories
2019
Bruce SachsVertex Pharmaceuticals Incorpor
2017
Theodore SamuelsPerrigo Company Plc
2017
Shlomo YanaiPerrigo Company Plc
N/A
Herman MorrisPerrigo Company Plc
1999
Bruce CarterDr Reddys Laboratories
2008
Michael BrownRegeneron Pharmaceuticals
1991
Joseph GoldsteinRegeneron Pharmaceuticals
1991
Jeffrey SmithPerrigo Company Plc
2017
Louise ParentZoetis Inc
2013
Anupam PuriDr Reddys Laboratories
2002

Company Summary

Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug ManufacturersGeneral classification in USA and is traded on BATS Exchange. It employs 88300 people.Pfizer Inc (PFE) is traded on BATS Exchange in USA and employs 88,300 people.

Pfizer Inc Leadership Team

John Young, Group President - Pfizer Innovative Health and Angela Hwang
Jennifer Damico, Senior Vice President Principal Accounting Officer, Controller
Frank DAmelio, Chief Financial Officer, Executive Vice President - Business Operations and Global Supply
Douglas Lankler, Executive Vice President General Counsel
Dawn Rogers, Chief Human Resource Officer, Executive Vice President
Helen Hobbs, Independent Director
Shantanu Narayen, Lead Independent Director
James Smith, Independent Director
Dennis Ausiello, Independent Director
Mikael Dolsten, Chief Scientific Officer, President - Worldwide Research, Development and Medical
Susan DesmondHellmann, Director
Frances Fergusson, Independent Director
Stephen Sanger, Independent Director
Lidia Fonseca, Executive Vice President, Chief Technology Officer and Digital Officer
Gordon Loh, Senior Vice President Corporate Audit
Wyllie Cornwell, Independent Director
Suzanne Johnson, Independent Director
Alexander Mackenzie, Executive Vice President Chief Development Officer
Geno Germano, Group President of Global Innovative Pharma Bus.
Laurie Olson, Executive Vice President - Strategy, Portfolio and Commercial Operations
Sally Susman, Chief Corporate Affairs Officer, Executive Vice President
Anthony Maddaluna, Executive Vice President and Presidentident - Pfizer Global Supply
Susan Hockfield, Independent Director
Freda LewisHall, Executive Vice President Chief Medical Officer
Rady Johnson, Chief Compliance, Quality and Risk Officer, Executive Vice President
Dan Littman, Independent Director
Ian Read, Chairman, CEO and Chairman of Executive Committee
James Kilts, Independent Director
Don Cornwell, Independent Director
James Quincey, Independent Director
Charles Hill, Executive Vice President - Worldwide Human Resources
Joseph Echevarria, Independent Director
Albert Bourla, Group President - Vaccines, Oncology and Consumer Healthcare Business
Kirsten LundJurgensen, Executive Vice President and Presidentident - Pfizer Global Supply
Angela Hwang, Group President, Pfizer Biopharmaceuticals Group
Scott Gottlieb, Independent Director
Ronald Blaylock, Independent Director
Kathrin Jansen, Senior Vice President - Vaccine Research & Development
Michael Goettler, Group President - Pfizer Upjohn

Stock Performance Indicators

Did you try this?

Run Equity Search Now

   

Equity Search

Search for activelly-traded equities including funds and ETFs from over 30 global markets
All  Next Launch Module

Currently Active Assets on Macroaxis

F   
Purchased over 500 shares of
few hours ago
Traded for 5.9
SNE   
Purchased over 40 shares of
few hours ago
Traded for 66.75
GOOG   
Purchased few shares of
few hours ago
Traded for 1439.22
VMW   
Purchased a lot of shares of
few hours ago
Traded for 152.94
V   
Purchased few shares of
few hours ago
Traded for 196.36
Please check Your Equity Center. Please also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page